(MedPage Today) — Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial presented at the recent Association for Research in…
Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/116039
Author :
Publish date : 2025-06-12 16:29:00
Copyright for syndicated content belongs to the linked Source.
